Menu
Not yet recruiting NCT06625658

Evaluation of DPA for Treatment of Upper Anterior Crowding

No phase Interventional Correction of Upper Crowding

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Direct printed clear aligners.
Who it may be relevant to
Registry conditions: Correction of Upper Crowding. Basic parameters: 18 years — 25 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evaluation of Direct 3D Printed Clear Aligners for Treatment of Maxillary Anterior Crowding:(Clinical Trial)

Overview

Evaluation of effectiveness of direct printed clear aligner in relive crowding in maxillary incisor

Detailed description

The present study will be performed to evaluate the effectiveness of direct 3D-printed aligners in the treatment of maxillary anterior teeth crowding

Interventions

  • Device Direct printed clear aligners
    chang aligner every 10 days

Primary outcome measures

  • Correction of Maxillary Anterior Teeth Crowding according to little irregularity index [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Adult paients .age 18-25y. patients with mild to moderate upper anterior crowding (1mm\_6mm)
  • Healthy compliant and motivated patient. full dentition except wisdom teeth.

Exclusion criteria

  • Previous orthodontic treatments. Any systemic disease, pregnancy, or lactating females, with a pocket depth of more than 5mm.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Al Azhar University — Cairo

Identifiers

NCT: NCT06625658 · ORTHO-109-2- N

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗